img

Global Drugs for Asthma and COPD Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Drugs for Asthma and COPD Market Insights, Forecast to 2034

Drugs used as treatments for asthma and COPD
Market Analysis and InsightsGlobal Drugs for Asthma and COPD Market
Global Drugs for Asthma and COPD market is expected to reach to US$ 48440 million in 2024, with a positive growth of %, compared with US$ 45700 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Drugs for Asthma and COPD industry is evaluated to reach US$ 68020 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
The market for drugs used in the treatment of asthma and chronic obstructive pulmonary disease (COPD) is expected to witness substantial growth in the coming years. The increasing prevalence of these respiratory disorders, growing awareness about their diagnosis and management, and advancements in drug therapies are key drivers of market expansion. Bronchodilators and corticosteroids are commonly prescribed medications for asthma and COPD, and the market for these drugs is highly competitive, with several pharmaceutical companies involved in their production and distribution. However, challenges such as high treatment costs, side effects, and the availability of generic alternatives may hinder market growth. Nonetheless, the drugs for asthma and COPD market holds significant opportunities for growth, driven by the rising global burden of these respiratory conditions and the continuous development of novel therapeutic options.
Report Covers
This report presents an overview of global Drugs for Asthma and COPD market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Drugs for Asthma and COPD market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco
Segment by Type
Inhalable & Nasal Spray
Oral
Others

Segment by Application


Asthma
COPD
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Drugs for Asthma and COPD introduction, etc. Drugs for Asthma and COPD Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Drugs for Asthma and COPD
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Asthma and COPD Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Inhalable & Nasal Spray
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Drugs for Asthma and COPD Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Asthma
1.3.3 COPD
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Asthma and COPD Market Perspective (2018-2029)
2.2 Global Drugs for Asthma and COPD Growth Trends by Region
2.2.1 Drugs for Asthma and COPD Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drugs for Asthma and COPD Historic Market Size by Region (2018-2024)
2.2.3 Drugs for Asthma and COPD Forecasted Market Size by Region (2024-2029)
2.3 Drugs for Asthma and COPD Market Dynamics
2.3.1 Drugs for Asthma and COPD Industry Trends
2.3.2 Drugs for Asthma and COPD Market Drivers
2.3.3 Drugs for Asthma and COPD Market Challenges
2.3.4 Drugs for Asthma and COPD Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drugs for Asthma and COPD by Players
3.1.1 Global Drugs for Asthma and COPD Revenue by Players (2018-2024)
3.1.2 Global Drugs for Asthma and COPD Revenue Market Share by Players (2018-2024)
3.2 Global Drugs for Asthma and COPD Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drugs for Asthma and COPD, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Drugs for Asthma and COPD Market Concentration Ratio
3.4.1 Global Drugs for Asthma and COPD Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Asthma and COPD Revenue in 2022
3.5 Global Key Players of Drugs for Asthma and COPD Head office and Area Served
3.6 Global Key Players of Drugs for Asthma and COPD, Product and Application
3.7 Global Key Players of Drugs for Asthma and COPD, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Asthma and COPD Breakdown Data by Type
4.1 Global Drugs for Asthma and COPD Historic Market Size by Type (2018-2024)
4.2 Global Drugs for Asthma and COPD Forecasted Market Size by Type (2024-2029)
5 Drugs for Asthma and COPD Breakdown Data by Application
5.1 Global Drugs for Asthma and COPD Historic Market Size by Application (2018-2024)
5.2 Global Drugs for Asthma and COPD Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drugs for Asthma and COPD Market Size (2018-2029)
6.2 North America Drugs for Asthma and COPD Market Size by Type
6.2.1 North America Drugs for Asthma and COPD Market Size by Type (2018-2024)
6.2.2 North America Drugs for Asthma and COPD Market Size by Type (2024-2029)
6.2.3 North America Drugs for Asthma and COPD Market Share by Type (2018-2029)
6.3 North America Drugs for Asthma and COPD Market Size by Application
6.3.1 North America Drugs for Asthma and COPD Market Size by Application (2018-2024)
6.3.2 North America Drugs for Asthma and COPD Market Size by Application (2024-2029)
6.3.3 North America Drugs for Asthma and COPD Market Share by Application (2018-2029)
6.4 North America Drugs for Asthma and COPD Market Size by Country
6.4.1 North America Drugs for Asthma and COPD Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drugs for Asthma and COPD Market Size by Country (2018-2024)
6.4.3 North America Drugs for Asthma and COPD Market Size by Country (2024-2029)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Drugs for Asthma and COPD Market Size (2018-2029)
7.2 Europe Drugs for Asthma and COPD Market Size by Type
7.2.1 Europe Drugs for Asthma and COPD Market Size by Type (2018-2024)
7.2.2 Europe Drugs for Asthma and COPD Market Size by Type (2024-2029)
7.2.3 Europe Drugs for Asthma and COPD Market Share by Type (2018-2029)
7.3 Europe Drugs for Asthma and COPD Market Size by Application
7.3.1 Europe Drugs for Asthma and COPD Market Size by Application (2018-2024)
7.3.2 Europe Drugs for Asthma and COPD Market Size by Application (2024-2029)
7.3.3 Europe Drugs for Asthma and COPD Market Share by Application (2018-2029)
7.4 Europe Drugs for Asthma and COPD Market Size by Country
7.4.1 Europe Drugs for Asthma and COPD Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drugs for Asthma and COPD Market Size by Country (2018-2024)
7.4.3 Europe Drugs for Asthma and COPD Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drugs for Asthma and COPD Market Size (2018-2029)
8.2 China Drugs for Asthma and COPD Market Size by Type
8.2.1 China Drugs for Asthma and COPD Market Size by Type (2018-2024)
8.2.2 China Drugs for Asthma and COPD Market Size by Type (2024-2029)
8.2.3 China Drugs for Asthma and COPD Market Share by Type (2018-2029)
8.3 China Drugs for Asthma and COPD Market Size by Application
8.3.1 China Drugs for Asthma and COPD Market Size by Application (2018-2024)
8.3.2 China Drugs for Asthma and COPD Market Size by Application (2024-2029)
8.3.3 China Drugs for Asthma and COPD Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Drugs for Asthma and COPD Market Size (2018-2029)
9.2 Asia Drugs for Asthma and COPD Market Size by Type
9.2.1 Asia Drugs for Asthma and COPD Market Size by Type (2018-2024)
9.2.2 Asia Drugs for Asthma and COPD Market Size by Type (2024-2029)
9.2.3 Asia Drugs for Asthma and COPD Market Share by Type (2018-2029)
9.3 Asia Drugs for Asthma and COPD Market Size by Application
9.3.1 Asia Drugs for Asthma and COPD Market Size by Application (2018-2024)
9.3.2 Asia Drugs for Asthma and COPD Market Size by Application (2024-2029)
9.3.3 Asia Drugs for Asthma and COPD Market Share by Application (2018-2029)
9.4 Asia Drugs for Asthma and COPD Market Size by Region
9.4.1 Asia Drugs for Asthma and COPD Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drugs for Asthma and COPD Market Size by Region (2018-2024)
9.4.3 Asia Drugs for Asthma and COPD Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Drugs for Asthma and COPD Introduction
11.1.4 GSK Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.1.5 GSK Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Drugs for Asthma and COPD Introduction
11.2.4 AstraZeneca Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.2.5 AstraZeneca Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Drugs for Asthma and COPD Introduction
11.3.4 Boehringer Ingelheim Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Vertex
11.4.1 Vertex Company Details
11.4.2 Vertex Business Overview
11.4.3 Vertex Drugs for Asthma and COPD Introduction
11.4.4 Vertex Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.4.5 Vertex Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Drugs for Asthma and COPD Introduction
11.5.4 Roche Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.5.5 Roche Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Drugs for Asthma and COPD Introduction
11.6.4 Novartis Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.6.5 Novartis Recent Developments
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Drugs for Asthma and COPD Introduction
11.7.4 Teva Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.7.5 Teva Recent Developments
11.8 Chiesi
11.8.1 Chiesi Company Details
11.8.2 Chiesi Business Overview
11.8.3 Chiesi Drugs for Asthma and COPD Introduction
11.8.4 Chiesi Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.8.5 Chiesi Recent Developments
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Drugs for Asthma and COPD Introduction
11.9.4 Mylan Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.9.5 Mylan Recent Developments
11.10 Sumitomo Dainippon
11.10.1 Sumitomo Dainippon Company Details
11.10.2 Sumitomo Dainippon Business Overview
11.10.3 Sumitomo Dainippon Drugs for Asthma and COPD Introduction
11.10.4 Sumitomo Dainippon Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.10.5 Sumitomo Dainippon Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Drugs for Asthma and COPD Introduction
11.11.4 Merck Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.11.5 Merck Recent Developments
11.12 Beximco
11.12.1 Beximco Company Details
11.12.2 Beximco Business Overview
11.12.3 Beximco Drugs for Asthma and COPD Introduction
11.12.4 Beximco Revenue in Drugs for Asthma and COPD Business (2018-2024)
11.12.5 Beximco Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drugs for Asthma and COPD Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Inhalable & Nasal Spray
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Drugs for Asthma and COPD Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Drugs for Asthma and COPD Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Drugs for Asthma and COPD Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Drugs for Asthma and COPD Market Share by Region (2018-2024)
Table 9. Global Drugs for Asthma and COPD Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Drugs for Asthma and COPD Market Share by Region (2024-2029)
Table 11. Drugs for Asthma and COPD Market Trends
Table 12. Drugs for Asthma and COPD Market Drivers
Table 13. Drugs for Asthma and COPD Market Challenges
Table 14. Drugs for Asthma and COPD Market Restraints
Table 15. Global Drugs for Asthma and COPD Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Drugs for Asthma and COPD Revenue Share by Players (2018-2024)
Table 17. Global Top Drugs for Asthma and COPD by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Asthma and COPD as of 2022)
Table 18. Global Drugs for Asthma and COPD Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Drugs for Asthma and COPD Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Drugs for Asthma and COPD, Headquarters and Area Served
Table 21. Global Key Players of Drugs for Asthma and COPD, Product and Application
Table 22. Global Key Players of Drugs for Asthma and COPD, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs for Asthma and COPD Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Drugs for Asthma and COPD Revenue Market Share by Type (2018-2024)
Table 26. Global Drugs for Asthma and COPD Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Drugs for Asthma and COPD Revenue Market Share by Type (2024-2029)
Table 28. Global Drugs for Asthma and COPD Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Drugs for Asthma and COPD Revenue Share by Application (2018-2024)
Table 30. Global Drugs for Asthma and COPD Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Drugs for Asthma and COPD Revenue Share by Application (2024-2029)
Table 32. North America Drugs for Asthma and COPD Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Drugs for Asthma and COPD Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Drugs for Asthma and COPD Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Drugs for Asthma and COPD Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Drugs for Asthma and COPD Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Drugs for Asthma and COPD Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Drugs for Asthma and COPD Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Drugs for Asthma and COPD Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Drugs for Asthma and COPD Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Drugs for Asthma and COPD Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Drugs for Asthma and COPD Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Drugs for Asthma and COPD Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Drugs for Asthma and COPD Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Drugs for Asthma and COPD Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Drugs for Asthma and COPD Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Drugs for Asthma and COPD Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Drugs for Asthma and COPD Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Drugs for Asthma and COPD Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Drugs for Asthma and COPD Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Drugs for Asthma and COPD Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Drugs for Asthma and COPD Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Drugs for Asthma and COPD Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Drugs for Asthma and COPD Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Drugs for Asthma and COPD Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Drugs for Asthma and COPD Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drugs for Asthma and COPD Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size by Country (2024-2029) & (US$ Million)
Table 64. GSK Company Details
Table 65. GSK Business Overview
Table 66. GSK Drugs for Asthma and COPD Product
Table 67. GSK Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 68. GSK Recent Developments
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Drugs for Asthma and COPD Product
Table 72. AstraZeneca Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 73. AstraZeneca Recent Developments
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Drugs for Asthma and COPD Product
Table 77. Boehringer Ingelheim Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Developments
Table 79. Vertex Company Details
Table 80. Vertex Business Overview
Table 81. Vertex Drugs for Asthma and COPD Product
Table 82. Vertex Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 83. Vertex Recent Developments
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Drugs for Asthma and COPD Product
Table 87. Roche Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 88. Roche Recent Developments
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Drugs for Asthma and COPD Product
Table 92. Novartis Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 93. Novartis Recent Developments
Table 94. Teva Company Details
Table 95. Teva Business Overview
Table 96. Teva Drugs for Asthma and COPD Product
Table 97. Teva Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 98. Teva Recent Developments
Table 99. Chiesi Company Details
Table 100. Chiesi Business Overview
Table 101. Chiesi Drugs for Asthma and COPD Product
Table 102. Chiesi Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 103. Chiesi Recent Developments
Table 104. Mylan Company Details
Table 105. Mylan Business Overview
Table 106. Mylan Drugs for Asthma and COPD Product
Table 107. Mylan Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 108. Mylan Recent Developments
Table 109. Sumitomo Dainippon Company Details
Table 110. Sumitomo Dainippon Business Overview
Table 111. Sumitomo Dainippon Drugs for Asthma and COPD Product
Table 112. Sumitomo Dainippon Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 113. Sumitomo Dainippon Recent Developments
Table 114. Merck Company Details
Table 115. Merck Business Overview
Table 116. Merck Drugs for Asthma and COPD Product
Table 117. Merck Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 118. Merck Recent Developments
Table 119. Beximco Company Details
Table 120. Beximco Business Overview
Table 121. Beximco Drugs for Asthma and COPD Product
Table 122. Beximco Revenue in Drugs for Asthma and COPD Business (2018-2024) & (US$ Million)
Table 123. Beximco Recent Developments
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Asthma and COPD Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Drugs for Asthma and COPD Market Share by Type: 2022 VS 2029
Figure 3. Inhalable & Nasal Spray Features
Figure 4. Oral Features
Figure 5. Others Features
Figure 6. Global Drugs for Asthma and COPD Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Drugs for Asthma and COPD Market Share by Application: 2022 VS 2029
Figure 8. Asthma Case Studies
Figure 9. COPD Case Studies
Figure 10. Drugs for Asthma and COPD Report Years Considered
Figure 11. Global Drugs for Asthma and COPD Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Drugs for Asthma and COPD Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Drugs for Asthma and COPD Market Share by Region: 2022 VS 2029
Figure 14. Global Drugs for Asthma and COPD Market Share by Players in 2022
Figure 15. Global Top Drugs for Asthma and COPD Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Asthma and COPD as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Drugs for Asthma and COPD Revenue in 2022
Figure 17. North America Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Drugs for Asthma and COPD Market Share by Type (2018-2029)
Figure 19. North America Drugs for Asthma and COPD Market Share by Application (2018-2029)
Figure 20. North America Drugs for Asthma and COPD Market Share by Country (2018-2029)
Figure 21. United States Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Drugs for Asthma and COPD Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Drugs for Asthma and COPD Market Share by Type (2018-2029)
Figure 25. Europe Drugs for Asthma and COPD Market Share by Application (2018-2029)
Figure 26. Europe Drugs for Asthma and COPD Market Share by Country (2018-2029)
Figure 27. Germany Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Drugs for Asthma and COPD Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Drugs for Asthma and COPD Market Share by Type (2018-2029)
Figure 35. China Drugs for Asthma and COPD Market Share by Application (2018-2029)
Figure 36. Asia Drugs for Asthma and COPD Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Drugs for Asthma and COPD Market Share by Type (2018-2029)
Figure 38. Asia Drugs for Asthma and COPD Market Share by Application (2018-2029)
Figure 39. Asia Drugs for Asthma and COPD Market Share by Region (2018-2029)
Figure 40. Japan Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Drugs for Asthma and COPD Market Share by Country (2018-2029)
Figure 50. Brazil Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Drugs for Asthma and COPD Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GSK Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 57. AstraZeneca Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 59. Vertex Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 60. Roche Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 61. Novartis Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 62. Teva Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 63. Chiesi Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 64. Mylan Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 65. Sumitomo Dainippon Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 66. Merck Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 67. Beximco Revenue Growth Rate in Drugs for Asthma and COPD Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries